Indian Generic Drugs Market to Grow at Splendid Pace

According to our latest report entitled “Booming Generics Drug Market in India”, generic drug market in India has witnessed fast growth during the past few years on the back of rising demand for cheaper medications. Factors, such as huge investments, low cost manufacturing capabilities, and the availability of highly skilled manpower resulted in a US$ 20 Billion generics market at the end of FY 2010. Further, the market is likely to grow at a CAGR of around 16.3% during FY 2011 - FY 2013.

 

Our report has found that, there are immense opportunities for Indian generics firms in regions, such as the US, Europe, Japan, and Africa. The US is the largest pharmaceutical market in the world and high healthcare cost calls for the availability of cheap medicines. Moreover, branded drugs going off-patent in coming years are likely to create a huge market for generic drugs. Same is the case with other regions also, who are looking towards India as a supplier of quality driven generics.

 

The report “Booming Generics Drug Market in India” identifies some of the prominent trends in Indian generics market, which are having a broad impact on the industry performance. The market players are focusing on rural areas for further expansion; biogenerics are attracting investments, specialized treatments are in demand and strategic collaborations are increasing. The report also covers key restraints and challenges that may hinder growth of the generics market.

 

The report is an outcome of an extensive research and prudent analysis of the Indian generics market, with emphasis on data reliability and content flow. The report covers almost all the key aspects of market and analyzes each one of them in the best manner. The future projection of key market areas in report makes use of effective methods and techniques. Last but not the least, the report also provides an illustration on key market players and outlines their strengths and weaknesses.

For more information visit: http://www.rncos.com/Report/IM256.htm